We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Structure of Viral Fusion Protein

By Biotechdaily staff writers
Posted on 25 Jan 2006
Virologists have used x-ray diffraction crystallography techniques to determine the structure of the parainfluenza virus fusion (F) protein in its metastable (pre-fusion) state.

Investigators at Northwestern University (Evanston, IL, USA)
stabilized the pre-fusion form of the F protein by the addition of a carboxy-terminal trimerization domain. More...
Then, they used advanced x-ray crystallography techniques to establish the structure of the F protein to a resolution of 2.85 angstroms. The details of their study were published in the January 5, 2006, issue of Nature.

The virus relies on F protein for attachment and penetration of the host cell membrane. The x-ray diffraction data showed that there were profound conformational differences between the pre- and post-fusion states, involving transformations in secondary and tertiary structure. "The protein in its metastable state has a very specific job to do--to enable infection of the cell--and it does this by essentially acting as a harpoon that shoots into the cell's membrane to bring about the fusion,” explained senior author Dr. Theodore S. Jardetzky, professor of biochemistry, molecular biology, and cell biology at Northwestern University.

"The development of antiviral drugs is helped by knowledge of the structure, shape, and mechanism of the target molecules, which is what we can now provide for the F protein,” said Dr. Jardetzky. "Knowing how the virus gets into the cell will allow us to better inhibit this key part of the viral life cycle.”






Related Links:
Northwestern University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.